Skip to main content
A

Anuh Pharma Ltd. — Investor Relations & Filings

Ticker · ANUHPHR ISIN · INE489G01022 LEI · 335800IVKUOYQSJUVH89 BSE.NS Manufacturing
Filings indexed 81 across all filing types
Latest filing 2025-08-26 Regulatory Filings
Country IN India
Listing BSE.NS ANUHPHR

About Anuh Pharma Ltd.

https://www.anuhpharma.com

Anuh Pharma Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, specializing in the production of Macrolides, including Erythromycin salts, Azithromycin, and Clarithromycin. Its product portfolio also encompasses Anti-TB agents such as Pyrazinamide and Ethambutol, Anti-malarials like Chloroquine Phosphate, and a range of Corticosteroids including Dexamethasone and Betamethasone. Operating with global quality standards, the company maintains certifications such as WHO-GMP, EU-GMP, and CEP. Anuh Pharma focuses on large-scale manufacturing and the supply of high-quality intermediates to pharmaceutical formulators worldwide. The organization leverages advanced chemical synthesis capabilities to serve diverse therapeutic segments, ensuring consistent supply chain reliability and regulatory compliance across international markets.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2025-08-26 English
Shareholders meeting
Regulatory Filings
2025-08-22 English
Investor Presentation
Regulatory Filings
2025-08-22 English
General Updates
Regulatory Filings
2025-08-20 English
Copy of Newspaper Publication
Regulatory Filings
2025-08-09 English
Appointment
Regulatory Filings
2025-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.